Actas dermo-sifiliograficasHumansAntibodiesMonoclonalHumanizedHidradenitis Suppurativa
Real World Evidence of Secukinumab and Bimekizumab in Hidradenitis Suppurativa: A Systematic Review and Meta-Analysis.
S Haselgruber, D Muñoz-Barba, A Soto-Moreno, C Cuenca-Barrales, S Arias-Santiago, A Molina-Leyva
Published: 202610.1016/j.ad.2025.104491
Abstract
BACKGROUND AND OBJECTIVES: Evidence for secukinumab and bimekizumab in hidradenitis suppurativa (HS) primarily comes from randomized clinical trials with selected patient populations. Conversely, real-world evidence (RWE) studies reflect broader pati…
Preview only. Read the full abstract at the source